Enzymatic activity toward poly(L-lactic acid) implants by Schakenraad, J.M. et al.
Enzymatic activity toward poly(L-lactic acid) 
implants 
J. M. Schakenraad 
University of Groningen, Department of Histology and Cell Biology, Oostersingel 69/1, 
9713 EZ Groningen, and Center for Biomedical Technology, Oostersingel 59, 9713 EZ Groningen, 
The Netherlands 
M. J. Hardonk 
University of Groningen, Department of Pathology, Oostersingel 63, 9713 EZ Groningen, The 
Netherlands 
J.  Feijen 
Twente University, Department of Chemical Technology, Postbus 217, 7500 AE Enschede, The 
Netherlands 
I. Molenaar and P. Nieuwenhuis 
University of Groningen, Department of Histology and Cell Biology, Oostersingel 6911, 9713 
EZ Groningen, The Netherlands 
Tissue reactions toward biodegradable 
poly(L-lactic acid) implants were monitored 
by studying the activity pattern of seven 
enzymes as a function of time: alkaline 
phosphatase, acid phosphatase, a-naphthyl 
acetyl esterase, P-glucuronidase, ATP-ase, 
NADH-reductase, and lactate dehydroge- 
nase. Cell types were identified by their 
specific enzyme patterns, their morphology 
and location. Special attention was paid to 
the enzyme patterns of macrophages, fi- 
broblasts and polymorphonuclear granu- 
locytes (PMNs), being involved in foreign 
body reactions or inflammatory responses. 
One day after implantation, an influx of 
neutrophilic and eosinophilic granulocytes 
was observed, coinciding with activity of 
alkaline phosphatase (PMNs) and P-glu- 
curonidase (eosinophils). From day 3 on, 
macrophages containing ATP-ase, acid 
phosphatase and esterase could be ob- 
served. From day 7 on, lactate dehydroge- 
nase, the enzyme normally involved in the 
conversion of lactic acid, and its coenzyme 
NADH-reductase were observed in macro- 
phages and fibroblasts. These two en- 
zymes demonstrated more activity than 
expected on basis of wound-healing reac- 
tions upon implantation of a nonbiodegrad- 
able, inert biomaterial (as, e.g., Teflon). It is 
concluded that the biodegradable poly 
(L-lactic acid) used in these implantation 
studies is tissue compatible, and evokes a 
foreign body reaction with minor macro- 
phage and giant cell activity, as observed 
during this 3-week implantation period. 
Most enzyme patterns were simply due to 
a wound-healing reaction. The slightly in- 
creased levels of LDH and NADH suggest 
the release of lactic acid from the implant, 
and thus confirms the biodegradable nature 
of this polymer. 
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Degradation of polymeric materials is a feature of considerable importance 
in the field of biomedical engineering and drug delivery. Degradation is 
sometimes desirable, for instance in the case of microcapsules for drug de- 
livery,’ or degradation needs to be avoided as for a polymeric cup of a hip 
prosthesis.2 Degradation of polymers can occur by the uptake of energy 
causing cleavage of covalent  bond^.^,^ This may be caused by an increase in 
temperature, exposure to x-rays, uv, y-radiation, or mechanical stress. 
Polymers containing hydrolysable bonds can be degraded by hydrolysis. 
It has been reported in literature that hydrolysis of polymers in the physi- 
ological environment may be catalyzed en~ymatically.~,~ The role of locally 
produced enzymes in the degradation process of polymeric material has 
already been investigated for many materials, e.g., poly(L-lactic acid), poly- 
(DL-hCtiC a ~ i d ) , ~ - ~  poly(glyco1ic acid),” polyglactin 910,11 polystyrene,** 
p~lypropylene,’~ poly(methylmethacry1ate) (PMMA), poly(ethy1enetereph- 
thalate) (PETP), Nylon 66,8 and many others (e.g., Ref. 14). 
Enzyme digestion of hydrolysable bonds of implanted polymers is usually 
not ob~erved,”~’ although Williams et al. demonstrated in vitro that enzymes 
could increase the rate of degradation of several nominally stable polymers 
as, e.g., PETP, PMMA, Nylon 66 or a p~ly(etherurethane).~-~~ 
In general, two classes of enzymes are of interest to be studied in the im- 
mediate surroundings of the implantation site. First the hydrolases, hy- 
drolytic enzymes like phoshatases, esterases, and aminopeptidases. These 
enzymes are predominantly lysosomal and are mostly contained within 
macrophages and giant cells. The second class of enzymes is represented by 
the oxidoreductases, providing a way for further hydrolytic breakdown. 
It is interesting to know to what extent the cells in the immediate environ- 
ment of an implanted biomaterial influence the in vivo degradation, e.g., by 
the production of specific enzymes.15 Marchant et al.16 described in detail the 
relations between different cell types present at an implanted poly-urethane 
interface as a function of time. Factors released by lymphocytes or PMNs 
can influence the number and activity of macrophages and giant cells at the 
polymeric interface. 
In a previous paper, we have dem~nst ra ted’~  that the tissue reaction 
against biodegradable hollow fibers of poly(L-lactic acid) could be described 
as a very mild foreign body reaction. The initial presence of granulocytes 
and macrophages may suggest an active attack toward the implants. The 
absence of lymphocytes indicates a nonspecific inflammatory response. 
Many questions however, remain on the actual contribution of the different 
cell types to the degradation of poly(L-lactic acid). 
In order to monitor tissue reactions toward subcutaneously implanted bio- 
degradable poly(L-lactic acid) hollow fibers, we tested the tissue in the im- 
mediate surroundings of such an implant for the activity pattern of seven 
enzymes and compared these patterns with a normal wound healing pro- 
cess and with a nondegradable material to investigate the net effect of the 
poly(L-lactic) acid on its surroundings. 
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MATERIALS AND METHODS 
Poly(L-lactic acid) implants 
Hollow fibers, intended for use as a drug release device, were spun of 
poly(L-lactic acid) (Initial M,: 1.59 X lo5) using a "dry-wet" coagulation 
spinning pr~cess.'~~'* The tube-in-orifice spinneret device contained an injec- 
tion tube with an outside diameter of 0.6 mm, an inside diameter of 0.4 mm, 
and an orifice diameter of 1.0 mm. The spinning dope was composed of 
80% dioxane, 15% poly(L-lactic acid), and 5% polyvinylpyrrolidine (PVP) at 
a temperature of 50°C; water was used as the internal and external coagulant. 
The dimensions of the implanted fibers were: length 1 cm, diameter 
0.7 mm, wall thickness 0.1 mm. The fiber consisted of a porous matrix with 
a dense non-porous skin (approx. 0.3 km) on both sides. The fibers were 
then heat-sealed at both ends.I7 
Gore-tex blood vessel prostheses (1-mm diameter) were used as a non- 
degradable reference material with minimal tissue reaction. 
Implantation procedures 
The poly(L-lactic acid) fibers were implanted subcutaneously (n  = 3) in 
female AO/BN rats of approximately 3 months of age weighing 200-250 g. 
A specially adapted syringe was used for this purpose. Rats were ether- 
anesthetized, shaved on their backs, and subsequently ethanol desinfected 
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before the fibers were im~1anted.l~ Two fibers were implanted in each rat. 
At day 1, day 3, 1 week, 2 weeks, and 3 weeks fibers were harvested in- 
cluding surrounding tissue. Wounds without the presence of a biomaterial 
were studied to achieve normal enzyme patterns. 
Enzyme histochemical procedures and tissue preparation 
After harvesting, the fibers with adherent tissue were snap frozen in freon 
at -80°C. Sections of 6 pm were cut using a Leitz 1720 digital cryostat. The 
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cryostat was operated at a temperature of -25°C. After cutting, the sections 
were stored at -20°C until staining. Alternating sections were stained with 
hematoxilin-eosin for cell identification and the determination of tissue 
organization. 
To demonstrate alkaline phosphatase, acid phosphatase, esterase, and 
ATP-ase, sections were fixed in a mixture of formaldehyde-Macrodex- 
calcium chloride (0.9% sodium chloride and 1 g calciumchloride in 10 mL 
40% formaldehyde and 90 mL 6% Macrodex) at 4°C for 10 min. For the 
demonstration of NADH-reductase, lactate dehydrogenase and 6-glu- 
curonidase, sections were fixed in acetone at -20°C for 30 min and subse- 
quently incubated with the relevant substrates. The incubation procedures 
for the individual enzymes are summarized in Table I. 
TABLE I 
Incubation Procedures for the Various Enzymes. The Enzyme, Its Substrate, Cofactors, 
and Coupling agent, the Buffer, pH, Incubation Time, and Temperature Are Shown 
Substrate, Cofactors, Buffer Incubation 
Enzyme and Coupling Agent and pH Time/Temp 
Alkaline phosphatase 
Acid phosphatase 
a-naphthyl acethyl 
esterase 
p-glycuronidase 
ATP-ase 
NADH 
reductase 
Lactate 
dehydrogenase 
0.2 mM naphtol AS-MX phosphoric 
acid (sodium salt). 
0.6 mg/mL fast blue BB 
1.6 mM magnesium sulfate 
1.0 mM naphtol AS-Bl phosphoric 
acid (sodium salt). 
1.6 mg/mL para-rosaniline and 
24 mM sodium nitrite put together 
at 4°C before mixing with 
incubation medium 
1.2 mM sodium a-naphthyl acetate. 
1.6 mg/mL para-rosaniline and 
24 mM sodium nitrite put together 
at 4°C before mixing with 
incubation medium 
0.25 mM naphtol-AS-B1 
p-glucuronic acid. 
0.6 mg/mL para-rosaniline and 
8.7 mM sodium nitrite put together 
at 4°C before mixing with 
incubation medium 
1.0 mM ATP 
0.01 mM magnesium sulfate 
3.6 mM lead nitrate 
2.3 mM NADH 
0.6 mM nitro blue tetrazolium 
0.2 M sodium lactate 
0.01 M potassium cyanide 
0.005 M magnesium chloride 
0.75 mM NAD 
0.1 M 
pH 8.9 
3.6 mM 
Michaelis 
barbiturate 
acetate 
pH 5.0 
0.2 M 
Phosphate 
pH 7.0 
TNS-HC1 
0.1 M 
Acetate 
pH 5.0 
0.08 M TRIS- 
maleic acid 
pH 7.2 
0.05 M 
Phosphate 
pH 7.6 
0.2 M 
Phosphate 
pH 7.4 
l h  
RT 
l h  
37°C 
30 min 
RT 
l h  
56°C 
45 min 
37°C 
15 min 
37°C 
45 min 
37°C 
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The activity of the various enzymes tested and their possible role in 
wound healing and tissue reactions toward the implanted biomaterial are 
briefly summarized. 
Alkaline phosphafase. This hydrolase is predominantly associated with the 
plasma membrane. PMN and fibroblast activity can be monitored by this 
enzyme. Blood vessel walls also stain with this enzyme. Angioblastic activ- 
ity of sprouting endothelium can thus be shown. 
Acid phosphatase is the most prominent lysosomal hydrolase, indicative of 
macrophage activity at the implant site. This enzyme hydrolyses phosphate 
esters. 
dVaphthyl acetyl esterase. This hydrolase catalyzes the hydrolysis of car- 
boxylic acid esters and is contained within the lysosomes, predominantly in 
macrophages and giant cells. It is also present in fat tissue. 
P-glucuronidase, a lysosomal hydrolase capable of hydrolysing esters of 
glucuronic acid, found diffusely in macrophages and fibroblasts, and in 
granular form in eosinophilic granulocytes at the implantation site. 
ATP-use. This hydrolase is associated with cell membranes and mitochon- 
dria and hydrolyses ATP to ADP; it functions in active transport across the 
cell membrane and phosphorylation. Cellular contents of this enzyme are 
increased with increasing cellular metabolic activity. 
NADH-reductase. This oxidoreductase functions anaerobically and is associ- 
ated with metabolic activity in mitochondria and endoplasmatic reticulum. 
It is not cell type specific. NADH coenzyme is converted to NAD+ along 
with the reduction of pyruvate to lactate (by lactate dehydrogenase (LDH)), 
and as such it can be helpful in monitoring low levels of LDH activity. 
High lactate dehydrogenase activity is normally observed in ischemic areas. 
In the absence of oxygen it reduces pyruvate to lactate, using NADH as a 
coenzyme. This oxidoreductase is associated with mitochondria and endo- 
plasmatic reticulum and is involved in cellular metabolic and respiratory 
functions. It is a useful indicator for cell metabolic activity but it is not cell 
type specific. 
Quantitation of enzyme activity 
The presence of enzymes at the implantation site was quantified morpho- 
logically by comparing the number of cells positive for a particular enzyme 
at different time intervals and comparing them with nonspecific background 
staining. Cellular morphology, enzyme pattern, and location were com- 
bined in the quantification and qualification of specific enzymatic activity 
for each cell type. The activity is represented by: 
+ + : very high activity > 50 cells positive 
+ : high activity > 25 cells positive < 50 
+/-: moderate activity < 25 cells positive 
- : no activity : no cells positive 
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Only positive cells in the immediate vicinity of the implants (about 15 cell 
layers induced by the trauma or the presence of the material) were quantified 
(macrophages, fibroblasts, and PMNs). Eosinophils in surrounding connec- 
tive tissue and other cells of specific interest with regard to the wound-healing 
or foreign body reaction were also monitored. Cells outside the fibrous cap- 
sule were not included in this study, unless they were of specific interest. 
RESULTS 
PoIyrnorphonucIear granulocytes represent the major cellular component 
during the first few days after implantation. Alkaline phosphatase, NADH 
reductase, and ATPase activity can be demonstrated in these granulocytes 
(Fig. 1A). Highest numbers of positive cells were observed at day 1 (Fig. 2), 
slowly decreasing to day 7. After day 7 no more PMNs were observed. 
Macrophages were observed at the implant site as soon as 1 day after im- 
plantation. Overall activity and number were highest from day 3 to 7 
(Fig. 1B). Then, the number of macrophages generally decreased showing 
reduced enzymatic activity, except for NADH and LDH (Figs. 3 and 7). 
Acid phosphatase activity was present in the macrophages during the 
whole test period (Fig. 4). Esterase showed a similar profile, with a peak ac- 
Figure 2. Alkaline Phosphatase at day 1 after implantation; PMNs are vis- 
ible throughout the section, though concentrated around the implant (ar- 
rows). Bar = 1.3 mm. 
536 SCHAKENRAAD ET AL. 
Figure 3. Lactate dehydrogenase at 3 weeks after implantation; M = 
macrophages, F = fibroblasts, S = smooth muscle cells of blood vessels. 
Bar = 520 pm. 
tivity between 3 and 7 days (Fig. 5). LDH and NADH reductase activity was 
observed from day 3 and was maintained or slightly increased until day 21 
(Figs. 3 and 7). Macrophage ATP-ase activity was only observed between 
days 3 and 7. Alkaline phospatase and P-glucuronidase, two enzymes not 
specific for macrophages, showed moderate to low activity during the en- 
tire test period. Occasionally giant cells were observed, demonstrating simi- 
lar enzymatic activity. 
Fibroblasts were identified at the implant site from approximately day 3 on 
(Fig. 1C). They were positive for alkaline phosphatase (Fig. 6 ) .  In accor- 
dance with increased cellular activity during the process of fibrous encapsu- 
lation (from day 7 on) fibroblasts showed increased ATP-ase activity. Some 
acid phosphatase as well as lactate dehydrogenase activity was observed 
from day 7 to 21 (Fig. 3).  The number of fibroblasts around the implant in- 
creased until the formation of the capsule was c ~ m p l e t e d . ~ ~  The number of 
fibroblasts then slowly decreased, whereas the amount of collagen slowly 
increased. 
Blood vessels. Sprouting endothelial cells showed alkaline phosphatase ac- 
tivity in the immediate surroundings of the implant, only at day 3 (Fig. 6 ) .  
By day 7 this activity had disappeared. Vascular smooth muscle cells con- 
tained normal levels of LDH (Fig. 3), NADH (Fig. 7), and ATPase (Fig. 8) 
throughout the entire test period. 
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Figure 4. Acid phosphatase at 3 weeks after implantation (A, overview); 
macrophages (M) around the implant are intensely stained, fibroblasts (F) 
stain diffusely (B, detail). Bar = 1.3 mm (A), resp. 520 pm (B). 
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Figure 5. Esterase at 1 week after implantation; macrophages (M) around 
the implant and lipid compounds (L) have been stained. The implant is dis- 
rupted from its original place. Bar = 520 pm. 
Figure 6. Alkaline phosphatase at 3 days after implantation; fibroblasts (F) 
around the implant stain diffusely, few remaining granulocytes (G) and 
sprouting blood vessels (B) can be observed. Bar = 520 pm. 
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Figure 7. NADH at 3 weeks after implantation; macrophages (M) at the 
implant surface demonstrate elevated levels of NADH, blood vessels (B) 
show normal NADH activity. Bar = 520 pm. 
Figure 8. ATPase at 3 weeks after implantation; fibroblasts (F) around the 
implant demonstrate increased activity; blood vessels (B) and nerves (N) are 
also shown. Bar = 520 pm. 
539 
540 SCHAKENRAAD ET AL. 
Eosinophilic granulocytes were only observed on the first and third day after 
implantation, and could be monitored by their granular appearance of 
P-glucuronidase. At day 7 and after, no eosinophils were observed. This 
profile was also observed in normal wound healing. 
Lymphocytes were hardly observed in any stage of the study. Apparently 
lymphocytes do not play a dom'inant role in the cellular response at the im- 
plant site of this synthetic polymer. 
DISCUSSION 
The application of enzyme histochemistry offers an additional tool to 
evaluate the polymer-tissue interaction in addition to the traditional mor- 
phologic and histologic eval~ation.~ 
A combination of cellular enzyme patterns, cell localization, and mor- 
phology resulted in enzyme profiles for the respective cell types. Enzyme 
profiles possibly different from those observed in normal wound healing2' 
could thus be studied. 
In studying the tissue response after implantation of a biomaterial, it has 
to be evaluated whether the cellular reactions are caused by the implant or 
by a simple wound healing process, i.e., would they also occur if the im- 
plant was not there or was completely b i o t ~ l e r a n t . ~ ~ , ~ ~  
The introduction of a biomaterial into the body results in tissue trauma. A 
sequence of cellular and humoral events is then set in motion, i.e., vascular 
and capillary dilatation, diapedesis of PMNs and formation of an exudate 
can be ~bserved.'~,~' PMNs migrate toward the site of implantation, fol- 
lowed by monocytes, transforming into macro phage^.'^ Proliferation of 
resident tissue macrophagesz4 is the alternative source for macrophage 
accumulation. Macrophages release factors that cause fibroblast migration 
and proliferation in an early stage;" in a later stage these macrophages pro- 
duce factors that stimulate fibroblasts to synthesize collagen. 
It has been demonstrated by R o s s ~ ~ ~ ~  that from the three classical stages 
in wound healing (inflammation (Fig. 9), proliferation, and reorganization) 
the first two stages are comparable for normal wounds and nonirritating 
implant sites but that the tissue repair time is usually longer for the latter. 
Enzymatic activity 
During the first days after implantation neutrophyls showed alkaline 
phosphatase, ATP-ase, and NADH reductase activity (Fig. 1A). Other in- 
vestigators have also demonstrated the presence of c011agenase~~ and elas- 
tase3' in neutrophils. These two enzymes are active in the removal of 
connective tissue debris from traumatized tissues. Neutrophils disappear 
after approximately 3 days if healing is uneventful and the implant is not 
toxic or causing mechanical stress." 
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Figure 9. Hematoxilin-Eosin staining at day 1 (A) and day 14 (B) after 
implantation; The inflammatory phase of the wound-healing reaction is 
demonstrated; many neutrophils and macrophages are visible around the 
implant at day 1 (A). At day 14 (B) several layers of macrophages and fibro- 
blasts can be seen around the implant. Bar = 520 pm (A), resp. 1.3 mm (B). 
Macrophages arriving at the implant site showed hydrolytic enzymatic 
activity from day 3 onward. By day 13, the enzyme profiles decreased to re- 
main low thereafter (Fig. 1B). If the implant had been toxic or caused me- 
chanical stress, macrophages would have remained at the implant site for 
extended periods, to eventually fuse to foreign body giant cells.22 At day 21 
only LDH and NADH showed levels above normal (Figs. 3 and 7). This 
might be related to the fact that the implanted material is made of poly(L- 
lactic acid). Upon degradation, oligomers of L-lactic acid and monomeric L- 
lactic acid will be released and may cause an increase in macrophage LDH 
activity, in which NADH is operating as a coenzyme. In a separate study17 it 
was demonstrated that significant giant cell activity could be observed when 
the implanted biomaterial was desintegrating at a high rate. In the case of 
this poly(L-lactic acid) implant, significant degradation could only be ob- 
served after approximately 1 year. The absence of giant cell activity 3 weeks 
after implantation can therefore be expected. 
542 
(b) 
Figure 9. (continued) 
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We observed endothelial cells in the vicinity of the implant at day 3 show- 
ing high levels of alkaline phosphatase (Fig. 6). This suggests that capillaries 
form vascular sprouts, growing toward the implanted foreign body. The 
macrophage angiogenic factoljl may be responsible for this phenomenon. 
Mast cells were observed, activated by tissue damage. Mast cells are 
known to produce histamine, serotonin, heparin, and hydrolytic enzymes. 
These release products induce vascular permeability and can be associated 
with slight edema at the implant site at very early stages. Mast cells do not 
play a direct role in the tissue reaction against the implanted biomaterials. 
Matlaga et al.32,33 already indicated that the shape and size of the implanted 
biomaterial is of crucial importance with regard to the degree of tissue reac- 
tion. They found that rod-shaped implants with a diameter smaller than 
1 mm were causing the least activation of surrounding tissue. The fact that 
an increased activation was found with larger implants may possibly be ex- 
plained by an increase of ischemia around implants with a larger diameter." 
The implants used in this paper were also rod-shaped and had a diameter 
of 0.7 mm. We observed that our hollow fiber implants were slightly com- 
pressed by the pressure of the skin causing the spherical diameter to become 
ovoid. This resulted in a slightly higher mechanical activation of surrounding 
tissue at the more convex lateral sides of the implant, showing somewhat 
higher enzymatic activity. 
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The implants studied are to be used for the controlled release of drugs, 
especially steroid hormones. The macrophages with their content of lyso- 
soma1 enzymes present directly adjacent to the implanted polymer are 
therefore directly in contact with the released drug. Allisonx already men- 
tioned the negative effect of lysosomal enzymes on drug efficiency. He 
studied the uptake of drug in lysosomes. The enzymes were either stabiliz- 
ing or Iabilizing the drug release rate. In some cases lysosomal hydrolases 
were degrading the drug molecule and the degradation products were exocy- 
tosed. It is unknown in what way hormones do influence tissue reactions, 
but the steroid hormones used in separate studied' are not metabolized in 
lysosomes or by lysosomal enzymes, and we therefore do not expect a 
negative influence of enzymatic activity on the efficiency of the drug. 
The main degradation mechanism involved in the breakdown of these 
poly(L-lactic acid) implants is simple hydrolysis, taking place in tissue fluids; 
intracellular breakdown of small debris however can not be excluded. The 
lactic acid used in these studies starts to degrade slowly; an exponential in- 
crease in degradation is only observed after 1 year, when the molecular 
weight of the bulk of the polymer material has dropped to approximately 
5000. The observation of intracellular debris, 3 weeks after implantation is 
therefore unlikely. 
Events as described in this paper concerning the tissue reaction upon im- 
plantation of poly(L-lactic acid) hollow fibers have been referred to by others 
as a low turnover foreign body granuloma. "," This classification, however, 
impliesz that the macrophages present are persistent for longer periods of 
time and form giant cells. A zone of macrophages, lymphocytes, and granu- 
locytes should persist around these giant cells with an encapsulating mem- 
brane of fibrous tissue. Since we did not observe most of these phenomena, 
the term "granuloma" does not fit the observations and should not be used 
in this context. We only observed an inflammatory reaction as a host response 
upon the traumatizing implantation of a biomaterial, followed by a wound- 
healing process that is somewhat prolonged, possibly as a result of mechani- 
cal irritation of tissue by the implant. 
It is concluded that the poly(L-lactic acid) hollow fibers used in these im- 
plantation studies are completely tissue compatible, comparable with a nor- 
mal wound-healing process and have a very low inflammatory potential. 
The slightly increased levels of LDH and NADH suggest the release of lactic 
acid, and thus confirms the biodegradable nature of this polymer. 
The authors gratefully acknowledge the assistance of Mrs. S. Huitema, Mrs. M. 
Schakenraad-Dolfing, I. Stokroos, D. Huizinga, H. Meiborg, J. A. Oosterbaan, and 
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